BioNTech SE (BNTX) Other financing activities (2019 - 2025)
BioNTech SE's (BNTX) quarterly Other financing activities came in at -$13.4 million in Q3 2025, down 54.96% year-on-year from -$29.8 million in Q3 2024, and up 10.7% quarter-over-quarter from -$15.1 million in Q2 2025.
BioNTech SE (BNTX) Other financing activities (2019 - 2025) Analysis & Trends
BioNTech SE has disclosed Other financing activities across 7 years of filings, most recently posting -$13.4 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -13.44 Mn |
| Sep 30, 2025 | -13.44 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Jun 30, 2025 | -15.06 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Mar 31, 2025 | -14.52 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Jun 30, 2024 | -24.66 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Mar 31, 2024 | -8.47 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Sep 30, 2023 | -338.55 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Jun 30, 2023 | -177.93 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Mar 31, 2023 | -312.66 Mn |
| Sep 30, 2022 | -658.81 Mn |
| Sep 30, 2022 | -658.81 Mn |